{"id":"W4394581977","doi":"10.1080/14728214.2024.2340723","title":"Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Dalhousie University","funders":"","keywords":"Medicine; Idiopathic pulmonary fibrosis; Nintedanib; Pirfenidone; Clinical trial; Intensive care medicine; Pulmonary fibrosis; Disease; Lung; Internal medicine; Fibrosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00373922,0.0008760472,0.003228888,0.001342849,0.0003513277,0.002392827,0.001552608,0.002262562,0.01000925],"category_scores_gemma":[0.004765248,0.0003293866,0.002753446,0.001723735,0.0005574402,0.00208685,0.0009176601,0.003184964,0.002813135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001098954,"about_ca_system_score_gemma":0.002600007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000876463,"about_ca_topic_score_gemma":0.002902538,"domain_scores_codex":[0.9988573,0.0004035261,0.0002033281,0.00009000835,0.0003205412,0.0001252426],"domain_scores_gemma":[0.9965338,0.001497588,0.0007140637,0.00008905394,0.0009047485,0.0002607055],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0016869,0.0003311695,0.0003947548,0.04452884,0.0005855173,0.000176221,0.0000823767,0.0003140881,0.001973012,0.002549184,0.06618769,0.8811904],"study_design_scores_gemma":[0.003154498,0.003086371,0.002324362,0.09027294,0.003229456,0.0009566589,0.0001686346,0.0004773997,0.001261878,0.004277714,0.890721,0.00006916832],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005995044,0.990209,0.0004163857,0.004244358,0.0009015382,0.0001980777,0.0003471973,0.00003982996,0.003044123],"genre_scores_gemma":[0.004086166,0.9846065,0.001444855,0.00665343,0.0008748505,0.0003917091,0.000498159,0.00002495741,0.001419408],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01000925,"threshold_uncertainty_score":0.03348428,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07169041454626408,"score_gpt":0.436137698945395,"score_spread":0.3644472843991309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}